Group One Trading’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
VVM
DS
Group One Trading's TPST Position: Q2 2024 in Review
Group One Trading sold out of Tempest Therapeutics (TPST) in Q2 2024, closing a stake of 822 shares — an estimated $35.6K sold.
Group One Trading first reported a position in TPST in Q1 2015 and held it in 17 quarters. The position peaked at $945K in Q2 2015. 24 funds tracked by Wall St. Rank hold TPST as of Q2 2024.
- Group One Trading reported no remaining Tempest Therapeutics position as of Q2 2024 after selling out during the quarter.
- Group One Trading sold 822 Tempest Therapeutics shares in Q2 2024, an estimated $35.6K.
- Group One Trading first reported a position in Tempest Therapeutics in Q1 2015 and held it in 17 quarters.
- Group One Trading's Tempest Therapeutics position peaked at $945K in Q2 2015.
- 24 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2024.
Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.